Catalent Inc (CTLT) Chair & CEO John R Chiminski Sold $4.7 million of Shares

Author's Avatar
Oct 09, 2019
Article's Main Image

Chair & CEO of Catalent Inc (30-Year Financial, Insider Trades) John R Chiminski (insider trades) sold 97,043 shares of CTLT on 10/07/2019 at an average price of $48.84 a share. The total sale was $4.7 million.

Catalent Inc is a drug development, delivery and supply partner company. It engages in advanced delivery technologies and development solutions for drugs, biologics, and consumer health products across US, Europe and other international markets. Catalent Inc has a market cap of $7.03 billion; its shares were traded at around $48.10 with a P/E ratio of 53.97 and P/S ratio of 2.73. Catalent Inc had annual average EBITDA growth of 2.30% over the past five years. GuruFocus has detected 3 severe warning signs with Catalent Inc. .

CEO Recent Trades:

  • Chair & CEO John R Chiminski sold 97,043 shares of CTLT stock on 10/07/2019 at the average price of $48.84. The price of the stock has decreased by 1.52% since.

For the complete insider trading history of CTLT, click here

.